Production of galactooligosaccharides using various combinations of the commercial β-galactosidases
| Autor: | Nikolay Shakhno, Ladislav Čurda, Alina Botvynko, Svatopluk Henke, Alena Bednářová |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
0301 basic medicine
chemistry.chemical_classification Time Factors Galactosidases Galactooligosaccharide Prebiotic medicine.medical_treatment Biophysics Galactose Oligosaccharides Cell Biology beta-Galactosidase Biochemistry 03 medical and health sciences chemistry.chemical_compound 030104 developmental biology 0302 clinical medicine Enzyme chemistry 030220 oncology & carcinogenesis Yield (chemistry) medicine Food science Lactose Molecular Biology |
| Zdroj: | Biochemical and Biophysical Research Communications. 517:762-766 |
| ISSN: | 0006-291X |
| DOI: | 10.1016/j.bbrc.2019.08.001 |
| Popis: | Galactooligosaccharides (GOS) are currently attracting considerable interest as prebiotic substances and can be prepared by transgalactosylation reactions from lactose using β-galactosidase. We applied various combinations of the commercial β-galactosidases, such as Nola Fit 5500, Saphera 2600 L, Maxilact LGI 5000 and Maxilact A4 MG to achieve the highest yield of GOS and reduced lactose content. The combination of the Maxilact LGI 5000 and Nola Fit 5500 resulted in amount of GOS 105 g L−1 with lactose content lower than 5 g L−1, whilst the combination of the Maxilact A4 MG and Maxilact LGI 5000 enzymes led to an increase in GOS to 141,1 g L−1 and decrease of the lactose content to 46,9 g L−1. The combination of enzymes produced a higher yield of GOS, reduced the concentration of lactose, eventually, increases the efficiency of galactooligosaccharides purification that could be potentially used in the further investigations. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect